Screener
Aquestive Therapeutics, Inc. AQST Royalty Expense
Royalty Expense at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RoyaltyExpense.
The source filing: Aquestive Therapeutics, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001398733-26-000042
FAQ
- What is Aquestive Therapeutics, Inc.'s royalty expense?
- Aquestive Therapeutics, Inc. (AQST) reported royalty expense of $972K in Q2 2026.
- How has Aquestive Therapeutics, Inc.'s royalty expense changed year-over-year?
- Aquestive Therapeutics, Inc.'s royalty expense decreased by 32.2% year-over-year, from $1.43M to $972K.
- What does royalty expense mean?
- Royalty Expense as reported by Aquestive Therapeutics, Inc. Common Stock.
Ask your AI about Aquestive Therapeutics, Inc.'s royalty expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude